Cancer Research Solutions
Cancer research breakthroughs begin within insight
Over the last few decades, innovations in cancer research have advanced at a rapid pace, with new targeted treatments and immunotherapies showing great promise. However, due to the heterogenous nature of the disease, therapy resistance – whether intrinsic or acquired – remains a huge challenge. Research that unlocks the molecular mechanisms behind cancer evolution may be a key to future drug discovery and, ultimately, may provide personalized combinational therapies to individuals, creating the potential for improved outcomes.
Explore the complexities of cancer hallmarks
Cancer hallmarks initially outlined over a decade ago describe the mechanisms acquired during tumor development and form the basis for ongoing research. We’re committed to helping you explore and unravel the complexities of interconnected hallmarks and developing those research findings into future targets.
With a diverse range of solutions to accelerate your research, we help scientists study all aspects of cancer, from genomics to precision medicine research and beyond.
The next big cancer breakthrough will begin with research. And that research can begin with you.
For research use only. Not for use in diagnostic procedures.
Explore our cancer research solutions
Cancer genomics
Cancer genomics aims to understand the genetic basis by which tumors proliferate and evolve under selection by its microenvironment, the immune system, and therapeutic intervention. Identifying the genetic and epigenetic changes at the root of cancer has improved our understanding of its biology and may lead to new methods of detecting and treating disease.
Epigenetic research reagents
NGS Workflows
CRISPR Technologies
Single-Cell Sequencing
Cancer cell biology
Cancer cell biology investigates the underlying differences between normal cells and cancer cells and elucidates basic mechanisms that drive the development and behavior of tumors. Understanding this biology, and the fundamental processes governing transformation, is critical for identifying future molecular targets for therapeutic or preventive intervention.
Targeted Protein Degradation
GPCR research reagents
Protein-protein interaction research reagents
Protein kinase research reagents
Cell Counting and Image Cytometry
Immuno-oncology
Immuno-oncology (I-O) is an especially exciting area of research because it harnesses the body’s immune system to fight cancers. However, to develop new ways to improve immune cell activity, you need a deep understanding of the complex relationship among tumor biology, tumor microenvironment, and the immune system.
Our wide range of tools helps support and advance your I-O research, redefining and developing tailored, life-changing immunotherapies to fight cancer.
Protein kinase research reagents
Cytokine Research Reagents
Multiomics and TotalSeq Reagents by BioLegend
In Vivo Imaging
Cellular Imaging & Analysis
Tumor Microenvironment
Imaging tumors within their microenvironments provides insights into complex interactions between cancer cells and surrounding immune cells, fibroblasts, signaling molecules, and extracellular matrices. Recent advances in tumor biology reveal these interactions control tumor growth and the development of metastasis, providing future targets for therapeutic intervention.
In Vivo Imaging
Multiomics and TotalSeq Reagents by BioLegend
Precision medicine research
Every cancer is unique, from their genetic makeup to their microenvironment. The future of individually tailored therapy research relies on developing our understanding of both the underlying genetics and functional responses of cancers to stay one step ahead.
Our complementary approaches allow you to screen an individuals’ molecular profiles to enable you to get the clarity you need in your research to identify the right target at the right time.
Functional Testing
ctDNA Workflows
Exosome/cfRNA Analysis
